Patents by Inventor Michael L. Vieira

Michael L. Vieira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF VILOXAZINE
    Publication number: 20230381191
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Application
    Filed: August 10, 2023
    Publication date: November 30, 2023
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. Vieira, Austin B. Huang, Padmanabh P. Bhatt
  • STABILIZED FORMULATIONS OF CNS COMPOUNDS
    Publication number: 20210322429
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • Stabilized formulations of CNS compounds
    Patent number: 11077114
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: August 3, 2021
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • FORMULATIONS OF VILOXAZINE
    Publication number: 20190201407
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Application
    Filed: March 8, 2019
    Publication date: July 4, 2019
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. VIEIRA, Austin B. HUANG, Padmanabh P. BHATT
  • Sustained-release formulations of topiramate
    Patent number: 10314790
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: June 11, 2019
    Assignee: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Formulations of viloxazine
    Patent number: 10265319
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: April 23, 2019
    Assignee: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Michael L. Vieira, Austin B. Huang, Padmanabh P. Bhatt
  • STABILIZED FORMULATIONS OF CNS COMPOUNDS
    Publication number: 20190060323
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun CHANG, Michael L. VIEIRA, Likan LIANG, Padmanabh P. BHATT, Austin B. HUANG, Sachin V. PATEL
  • Stabilized formulations of CNS compounds
    Patent number: 10149853
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: December 11, 2018
    Assignee: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20170266121
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: March 30, 2017
    Publication date: September 21, 2017
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan LIANG, Hua WANG, Padmanabh P. BHATT, Michael L. VIEIRA
  • FORMULATIONS OF VILOXAZINE
    Publication number: 20170258801
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Application
    Filed: May 25, 2017
    Publication date: September 14, 2017
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. VIEIRA, Austin B. HUANG, Padmanabh P. BHATT
  • Formulations of viloxazine
    Patent number: 9662338
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: May 30, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. Vieira, Austin B. Huang, Padmanabh P. Bhatt
  • Sustained-release formulations of topiramate
    Patent number: 9622983
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: April 18, 2017
    Assignee: Supernus Pharmaceutcals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Formulations of viloxazine
    Patent number: 9603853
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: March 28, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. Vieira, Austin B. Huang, Padmanabh P. Bhatt
  • Sustained-release formulations of topiramate
    Patent number: 9555004
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: January 31, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 9549940
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: January 24, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20160375048
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 29, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan LIANG, Hua WANG, Padmanabh P. BHATT, Michael L. VIEIRA
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20160375047
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 29, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan LIANG, Hua WANG, Padmanabh P. BHATT, Michael L. VIEIRA
  • FORMULATIONS OF VILOXAZINE
    Publication number: 20160279136
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Application
    Filed: June 3, 2016
    Publication date: September 29, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. VIEIRA, Austin B. HUANG, Padmanabh P. BHATT
  • FORMULATIONS OF VILOXAZINE
    Publication number: 20160256465
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Application
    Filed: May 18, 2016
    Publication date: September 8, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. VIEIRA, Austin B. HUANG, Padmanabh P. BHATT
  • Formulations of viloxazine
    Patent number: 9358204
    Abstract: Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: June 7, 2016
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Michael L. Vieira, Austin B. Huang, Padmanabh P. Bhatt